OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Food and Drug Administration Safety and Innovation Act

Floor Speech

Date: May 24, 2012
Location: Washington, DC
Issues: Health and Health Care

BREAK IN TRANSCRIPT

Mr. KERRY. Madam President, this would be the first time Congress has ever interfered in an FDA-based, science-based approval process. If we open that, we would be opening an extraordinary can of worms.

I urge my colleagues to oppose this amendment.

BREAK IN TRANSCRIPT


Source
arrow_upward